Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 218

1.

Kaposi sarcoma among people living with HIV in the French DAT'AIDS cohort between 2010 and 2015.

Poizot-Martin I, Obry-Roguet V, Duvivier C, Lions C, Huleux T, Jacomet C, Ferry T, Cheret A, Allavena C, Bani-Sadr F, Palich R, Cabié A, Fresard A, Pugliese P, Delobel P, Lamaury I, Hustache-Mathieu L, Brégigeon S, Makinson A, Rey D; Dat'AIDS study group.

J Eur Acad Dermatol Venereol. 2020 Jan 17. doi: 10.1111/jdv.16204. [Epub ahead of print]

PMID:
31953902
2.

Multimorbidity in Elderly Subjects according to the year of diagnosis of HIV-Infection - A Cross-Sectional DATAIDS Cohort Study.

Demontès M, Eymard Duvernay S, Allavena C, Jovelin T, Reynes J, Hentzien M, Ravaux I, Delobel P, Bregigeon S, Rey D, Ferry T, Gagneux-Brunon A, Robineau O, Pugliese P, Duvivier C, Cabié A, Chirouze C, Jacomet C, Lamaury I, Merrien D, Hoen B, Hocqueloux L, Cheret A, Katlama C, Arvieux C, Krolak-Salmon P, Makinson A; Dat’AIDS Study Group.

Clin Infect Dis. 2019 Dec 9. pii: ciz1171. doi: 10.1093/cid/ciz1171. [Epub ahead of print]

PMID:
31813982
3.

Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.

Le Guillou A, Pugliese P, Raffi F, Cabie A, Cuzin L, Katlama C, Allavena C, Drame M, Cotte L, Bani-Sadr F; Dat’AIDS Study Group .

Clin Infect Dis. 2019 Aug 17. pii: ciz800. doi: 10.1093/cid/ciz800. [Epub ahead of print]

PMID:
31612225
4.

Sarcoma patients' quality of life from diagnosis to yearly follow-up: experience from an Italian tertiary care center.

Maggi G, Terrenato I, Giacomelli L, Zoccali C, Condoleo MF, Falcicchio C, Baldi J, Vari S, Ferraresi V, Biagini R, Pugliese P.

Future Oncol. 2019 Sep;15(27):3125-3134. doi: 10.2217/fon-2019-0237. Epub 2019 Sep 12.

PMID:
31512484
5.

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat'AIDS cohort.

Cuzin L, Cotte L, Delpierre C, Allavena C, Valantin MA, Rey D, Delobel P, Pugliese P, Raffi F, Cabié A; Dat’AIDS Study group.

PLoS One. 2019 Sep 6;14(9):e0222067. doi: 10.1371/journal.pone.0222067. eCollection 2019.

6.

The Median Nerve Injury Model in Pre-clinical Research - A Critical Review on Benefits and Limitations.

Ronchi G, Morano M, Fregnan F, Pugliese P, Crosio A, Tos P, Geuna S, Haastert-Talini K, Gambarotta G.

Front Cell Neurosci. 2019 Jun 28;13:288. doi: 10.3389/fncel.2019.00288. eCollection 2019. Review.

7.

The unmet need for oncofertility preservation in women: Results of a survey by different oncological specialists in Lazio, Italy.

Fabi A, Lanzetta G, Vizza E, Corsi D, Moscetti L, Spinelli G, Mentuccia L, Lalle M, Perrone M, Baiocco L, Falcicchio C, Milani A, Giannarelli D, Cognetti F, Pugliese P.

Curr Probl Cancer. 2019 Dec;43(6):100479. doi: 10.1016/j.currproblcancer.2019.05.002. Epub 2019 May 17.

PMID:
31126661
8.

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D; Dat’AIDS Study Group.

PLoS One. 2019 Apr 18;14(4):e0215464. doi: 10.1371/journal.pone.0215464. eCollection 2019.

9.

Subtilase activity and gene expression during germination and seedling growth in barley.

Galotta MF, Pugliese P, Gutiérrez-Boem FH, Veliz CG, Criado MV, Caputo C, Echeverria M, Roberts IN.

Plant Physiol Biochem. 2019 Jun;139:197-206. doi: 10.1016/j.plaphy.2019.03.021. Epub 2019 Mar 16.

PMID:
30908971
10.

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort.

Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F; Dat’AIDS Study Group.

BMJ Open. 2019 Jan 25;9(1):e024841. doi: 10.1136/bmjopen-2018-024841.

11.

Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.

Cuzin L, Pugliese P, Katlama C, Bani-Sadr F, Ferry T, Rey D, Lourenco J, Bregigeon S, Allavena C, Reynes J, Cabié A; Dat’AIDS Study Group.

J Antimicrob Chemother. 2019 Mar 1;74(3):754-760. doi: 10.1093/jac/dky497.

PMID:
30534993
12.

Kinesins in neurological inherited diseases: a novel motor-domain mutation in KIF5A gene in a patient from Southern Italy affected by hereditary spastic paraplegia.

Citrigno L, Magariello A, Pugliese P, Di Palma G, Conforti FL, Petrone A, Muglia M.

Acta Neurol Belg. 2018 Dec;118(4):643-646. doi: 10.1007/s13760-018-1039-0. Epub 2018 Nov 9.

PMID:
30411208
13.

Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.

Pugliese P, Joly V, Valantin MA, Cotte L, Huleux T, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Cuzin L; Dat’AIDS group.

Med Mal Infect. 2019 Jun;49(4):264-269. doi: 10.1016/j.medmal.2018.10.005. Epub 2018 Nov 5.

PMID:
30409541
14.

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabié A, Raffi F; Dat’AIDS study group.

PLoS One. 2018 Sep 21;13(9):e0203895. doi: 10.1371/journal.pone.0203895. eCollection 2018.

15.

Nerve repair and regeneration: Biological tubulization limits and future perspectives.

Riccio M, Marchesini A, Pugliese P, De Francesco F.

J Cell Physiol. 2019 Apr;234(4):3362-3375. doi: 10.1002/jcp.27299. Epub 2018 Sep 12. Review.

PMID:
30206940
16.

A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.

Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.

Parkinsonism Relat Disord. 2018 Sep;54:3-8. doi: 10.1016/j.parkreldis.2018.07.016. Epub 2018 Jul 25.

PMID:
30068492
17.

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.

Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F; Dat'AIDS study group.

Aliment Pharmacol Ther. 2018 Aug;48(3):281-289. doi: 10.1111/apt.14812. Epub 2018 Jun 14.

18.

Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.

Hentzien M, Cabie A, Pugliese P, Billaud É, Poizot-Martin I, Duvivier C, Valantin MA, Kaladjian A, Dramé M, Bani-Sadr F; Dat'AIDS Study Group.

HIV Med. 2018 Jun 1. doi: 10.1111/hiv.12633. [Epub ahead of print]

PMID:
29856132
19.

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score.

Hentzien M, Delpierre C, Pugliese P, Allavena C, Jacomet C, Valantin MA, Cabié A, Cuzin L, Rey D, Bani-Sadr F, Dramé M; Dat’Aids Study Group.

PLoS One. 2018 Apr 19;13(4):e0195725. doi: 10.1371/journal.pone.0195725. eCollection 2018.

20.

Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.

Pradat P, Huleux T, Raffi F, Delobel P, Valantin MA, Poizot-Martin I, Pugliese P, Reynes J, Rey D, Hoen B, Cabie A, Bani-Sadr F, Cheret A, Duvivier C, Jacomet C, Fresard A, Hustache-Mathieu L, Cotte L; Dat’AIDS study Group.

AIDS. 2018 May 15;32(8):1077-1082. doi: 10.1097/QAD.0000000000001789.

PMID:
29438195
21.

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination.

Virlogeux V, Zoulim F, Pugliese P, Poizot-Martin I, Valantin MA, Cuzin L, Reynes J, Billaud E, Huleux T, Bani-Sadr F, Rey D, Frésard A, Jacomet C, Duvivier C, Cheret A, Hustache-Mathieu L, Hoen B, Cabié A, Cotte L; Dat’AIDS Study Group.

BMC Med. 2017 Dec 18;15(1):217. doi: 10.1186/s12916-017-0979-1.

22.

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study.

Cuzin L, Pugliese P, Allavena C, Rey D, Chirouze C, Bani-Sadr F, Cabié A, Huleux T, Poizot-Martin I, Cotte L, Isnard Bagnis C, Flandre P; Dat’AIDS study group.

PLoS One. 2017 Dec 7;12(12):e0187517. doi: 10.1371/journal.pone.0187517. eCollection 2017.

23.

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.

Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C; Dat’AIDS Study Group.

J Antimicrob Chemother. 2017 Dec 1;72(12):3502. doi: 10.1093/jac/dkx383. No abstract available.

PMID:
29121210
24.

Freezing Temperatures, Ice Nanotubes Structures, and Proton Ordering of TIP4P/ICE Water inside Single Wall Carbon Nanotubes.

Pugliese P, Conde MM, Rovere M, Gallo P.

J Phys Chem B. 2017 Nov 16;121(45):10371-10381. doi: 10.1021/acs.jpcb.7b06306. Epub 2017 Nov 2.

PMID:
29040802
25.

Below Knee Stump Reconstruction with a Foot Fillet Flap.

Tos P, Antonini A, Pugliese P, Panero B, Ciclamini D, Battiston B.

J Reconstr Microsurg. 2017 Oct;33(S 01):S20-S26. doi: 10.1055/s-0037-1606538. Epub 2017 Oct 6. Review. No abstract available.

PMID:
28985635
26.

Trends in the choice of first line treatment for hormone - responsive (HR+), human epidermal growth factor receptor - 2 negative (HER2-) metastatic breast cancer (MBC) patients (pts): results of a multicentric Italian observational study.

D' Alonzo A, Bighin C, Puglisi F, Gerratana L, De Laurentis M, Fontana A, Pugliese P, Ferzi A, Montemurro F, Arpino G, Poggio F, Vaglica M, Dellepiane C, Blondeaux E, Benedetta C, Cognetti F, Garrone O, Turletti A, Pastorino S, Del Mastro L.

Ann Oncol. 2017 Oct;28 Suppl 6:vi25. doi: 10.1093/annonc/mdx424. No abstract available.

27.

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.

Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C; Dat’AIDS Study Group.

J Antimicrob Chemother. 2017 Dec 1;72(12):3425-3434. doi: 10.1093/jac/dkx300. Erratum in: J Antimicrob Chemother. 2017 Dec 1;72(12):3502.

PMID:
28961719
28.

Ageing with HIV: do comorbidities and polymedication drive treatment optimization?

Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A; Dat'AIDS Study Group.

HIV Med. 2017 Jul;18(6):395-401. doi: 10.1111/hiv.12441. Epub 2016 Oct 7.

29.

No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.

Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Delpierre C; Dat'AIDS Study Group.

HIV Med. 2018 Mar;19(3):238-242. doi: 10.1111/hiv.12545. Epub 2017 Aug 18.

PMID:
28834136
30.

Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?

Pradat P, Pugliese P, Poizot-Martin I, Valantin MA, Cuzin L, Reynes J, Billaud E, Huleux T, Bani-Sadr F, Rey D, Frésard A, Jacomet C, Duvivier C, Cheret A, Hustache-Mathieu L, Hoen B, Cabié A, Cotte L; Dat'AIDS study Group.

J Infect. 2017 Sep;75(3):234-241. doi: 10.1016/j.jinf.2017.05.008. Epub 2017 Jun 2.

PMID:
28579302
31.

The course of cancer related fatigue up to ten years in early breast cancer patients: What impact in clinical practice?

Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P.

Breast. 2017 Aug;34:44-52. doi: 10.1016/j.breast.2017.04.012. Epub 2017 May 11.

PMID:
28500901
32.

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.

Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D; Dat'AIDS study group.

HIV Med. 2017 Oct;18(9):704-708. doi: 10.1111/hiv.12506. Epub 2017 Apr 26. No abstract available.

33.

Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization.

Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G; DatʼAIDS Study Group.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e23-e26. doi: 10.1097/QAI.0000000000001397. No abstract available.

PMID:
28418992
34.

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.

Cotte L, Ferry T, Pugliese P, Valantin MA, Allavena C, Cabié A, Poizot-Martin I, Rey D, Duvivier C, Cheret A, Dellamonica P, Pradat P, Parienti JJ; Dat’AIDS study group.

PLoS One. 2017 Feb 2;12(2):e0170661. doi: 10.1371/journal.pone.0170661. eCollection 2017.

35.

Quality of life improvement in HIV-1 patients treated with raltegravir in a real-life observational study: RACING.

Spire B, Nait-Ighil L, Pugliese P, Poizot-Martin I, Jullien V, Marcelin AG, Billaud E.

HIV Clin Trials. 2017 Jan;18(1):1-16. doi: 10.1080/15284336.2016.1251030.

PMID:
28125951
36.

Irreversible changes occurring in long-term denervated Schwann cells affect delayed nerve repair.

Ronchi G, Cillino M, Gambarotta G, Fornasari BE, Raimondo S, Pugliese P, Tos P, Cordova A, Moschella F, Geuna S.

J Neurosurg. 2017 Oct;127(4):843-856. doi: 10.3171/2016.9.JNS16140. Epub 2017 Jan 6.

PMID:
28059646
37.

COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated.

Risso K, Guillouet-de-Salvador F, Valerio L, Puglièse P, Naqvi A, Durant J, Demonchy E, Perbost I, Cua E, Marquette CH, Roger PM.

PLoS One. 2017 Jan 5;12(1):e0169359. doi: 10.1371/journal.pone.0169359. eCollection 2017.

38.

Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.

Gantner P, Bani-Sadr F, Garraffo R, Roger PM, Treger M, Jovelin T, Pugliese P, Rey D; Dat’AIDS cohort.

PLoS One. 2016 Oct 31;11(10):e0164240. doi: 10.1371/journal.pone.0164240. eCollection 2016.

39.

MR parkinsonism index predicts vertical supranuclear gaze palsy in patients with PSP-parkinsonism.

Quattrone A, Morelli M, Williams DR, Vescio B, Arabia G, Nigro S, Nicoletti G, Salsone M, Novellino F, Nisticò R, Pucci F, Chiriaco C, Pugliese P, Bosco D, Caracciolo M.

Neurology. 2016 Sep 20;87(12):1266-73. doi: 10.1212/WNL.0000000000003125. Epub 2016 Aug 24.

40.

Hepatitis C treatment initiation in HIV-HCV coinfected patients.

Cotte L, Pugliese P, Valantin MA, Cuzin L, Billaud E, Duvivier C, Naqvi A, Cheret A, Rey D, Pradat P, Poizot-Martin I; Dat’AIDS study Group.

BMC Infect Dis. 2016 Jul 22;16:345. doi: 10.1186/s12879-016-1681-1.

41.

Rehabilitation pathways in adult brain tumor patients in the first 12 months of disease. A retrospective analysis of services utilization in 719 patients.

Pace A, Villani V, Parisi C, Di Felice S, Lamaro M, Falcicchio C, Bonucci A, Pugliese P, di Napoli A, Di Lallo D.

Support Care Cancer. 2016 Nov;24(11):4801-6. doi: 10.1007/s00520-016-3333-9. Epub 2016 Jul 15.

PMID:
27422655
42.

Impact of age on care pathways of people living with HIV followed up in hospital.

Jacomet C, Berland P, Guiguet M, Simon A, Rey D, Arvieux C, Pugliese P, Gerbaud L.

AIDS Care. 2017 Jan;29(1):105-111. Epub 2016 Jun 23.

PMID:
27334840
43.

Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.

Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L; Dat'AIDS Study group.

HIV Med. 2016 May;17(5):380-4. doi: 10.1111/hiv.12306. Epub 2015 Aug 26.

44.

Autoantibodies specific to estrogen receptor alpha act as estrogen agonists and their levels correlate with breast cancer cell proliferation.

Maselli A, Capoccia S, Pugliese P, Raggi C, Cirulli F, Fabi A, Malorni W, Pierdominici M, Ortona E.

Oncoimmunology. 2015 Aug 12;5(2):e1074375. eCollection 2016 Feb.

45.

Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease.

Hentzien M, Dramé M, Allavena C, Jacomet C, Valantin MA, Cabié A, Cuzin L, Rey D, Pugliese P, Bani-Sadr F; Dat'AIDS Study Group.

J Nutr Health Aging. 2016 Apr;20(4):408-14. doi: 10.1007/s12603-015-0608-7.

PMID:
26999241
46.

Longitudinal changes of endocrine and bone disease in adults with β-thalassemia major receiving different iron chelators over 5 years.

Poggi M, Sorrentino F, Pugliese P, Smacchia MP, Daniele C, Equitani F, Terlizzi F, Guitarrini MR, Monti S, Maffei L, Losardo A, Pasin M, Toscano V.

Ann Hematol. 2016 Apr;95(5):757-63. doi: 10.1007/s00277-016-2633-y. Epub 2016 Mar 9.

PMID:
26957357
47.

Does first-line antiretroviral regimen impact risk for chronic kidney disease whatever the risk group?

Flandre P, Pugliese P, Allavena C, Isnard Bagnis C, Cuzin L; Dat’AIDS study Group.

AIDS. 2016 Jun 1;30(9):1433-8. doi: 10.1097/QAD.0000000000001065.

PMID:
26891036
48.

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.

Allavena C, Katlama C, Cotte L, Roger PM, Delobel P, Cheret A, Duvivier C, Poizot-Martin I, Hoen B, Cabie A, Cheret A, Lahoulou R, Raffi F, Pugliese P; Dat’AIDS Study group.

Infect Dis (Lond). 2016;48(5):392-8. doi: 10.3109/23744235.2015.1133927. Epub 2016 Jan 13.

PMID:
26757613
49.

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients.

Poizot-Martin I, Naqvi A, Obry-Roguet V, Valantin MA, Cuzin L, Billaud E, Cheret A, Rey D, Jacomet C, Duvivier C, Pugliese P, Pradat P, Cotte L; Hepadat'AIDS Study Group.

PLoS One. 2015 Oct 21;10(10):e0141164. doi: 10.1371/journal.pone.0141164. eCollection 2015.

50.

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach.

Cuzin L, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Flandre P; Dat'AIDS Study group.

Medicine (Baltimore). 2015 Sep;94(39):e1668. doi: 10.1097/MD.0000000000001668.

Supplemental Content

Loading ...
Support Center